echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > TAG: Plateplate-to-lymphocyte percentage index is a simple non-invasive tool for monitoring endoscopic activity in Crohn's disease

    TAG: Plateplate-to-lymphocyte percentage index is a simple non-invasive tool for monitoring endoscopic activity in Crohn's disease

    • Last Update: 2021-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Crohn's disease (CD) is a chronic gastrointestinal inflammatory disease characterized by relapse and remission.
    about half of CD patients have intestinal complications, such as stenosis or fistula.
    , close monitoring of disease activity throughout the disease of CD is essential.
    currently, endoscopy is considered the primary means of checking the degree of disease relief of CD.
    , however, endoscopy is invasive, uncomfortable, time-consuming and expensive, and not suitable for routine use.
    , precise and reliable non-invasive alternative markers are needed to assess the severity of CD endoscope disease activity.
    recent evidence of abnormal whole blood cell count (CBC) in CD patients.
    many studies have found that some conventional CBC blood indicators, such as red blood cell distribution width, plate plate count, average plate plate volume, and plateboard generation ratio (PCT), can be used as biomarkers to monitor disease activity in CD patients.
    some indirect parameters, such as the ratio of neophils to lymphocytes and plateboard to lymphocytes, have also been used to determine the activity of the disease.
    therefore, the purpose of this study is to build a simple model consisting of blood parameters from traditional hematological tests that reliably reflect the severity of CD endoscopic disease activity.
    researchers conducted a retrospective analysis of confirmed CD patients who underscopyed clinically at four level 3 medical centers in China between 2016 and 2020.
    endoscopic score of CD, CBC parameters, C-reactive protein (CRP) level, individual variable rate of red blood cell seidation, and... MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.